We experimentally validated this mode of actions of fb-PMT by demonstrating that anticancer effects of suboptimal 50% inhibitory doses of fb-PMT on human GBM cells could be rescued by GDNF in a dose-dependent manner (Supplementary Figure S3B and E). This evidence concerns the gene GDNF and glioblastoma.